Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-03-07

Clinical Trial Update: Gabapentin in the Prevention of Nausea and Vomiting Induced by Chemotherapy [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Gabapentin to prevent chemotherapy-induced nausea and vomiting has completed, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gabapentin (Gabapentin)

Snippet

Sponsor: Faculdade de Medicina do ABC | Conditions: Vomiting, Cisplatin Adverse Reaction | Phase 3 | Status: COMPLETED | Results posted: 2014-03-07